{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:11:04Z","timestamp":1766869864070},"reference-count":16,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1524-4741.2011.01161.x","type":"journal-article","created":{"date-parts":[[2011,10,6]],"date-time":"2011-10-06T03:09:41Z","timestamp":1317870581000},"page":"272-275","source":"Crossref","is-referenced-by-count":6,"title":["Low-Dose Cyclophosphamide Associated with Hemorrhagic Cystitis in a Breast Cancer Patient"],"prefix":"10.1155","volume":"18","author":[{"given":"Ariela","family":"Marshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Torigian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Papanicolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol Kaplan","family":"Tweed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5347(17)41173-6","article-title":"Urological complications of cyclophosphamide","volume":"141","author":"Levine","year":"1989","journal-title":"J Urol"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB2|cit2","first-page":"942","article-title":"Haemorrhagic cystitis and cyclophosphamide","volume":"2","author":"Spiers","year":"1963","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-4295(82)90633-1","article-title":"Prevention of cyclophosphamide-induced hemorrhagic cystitis","volume":"20","author":"Droller","year":"1982","journal-title":"Urology"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/1097-0142(196410)17:10<1348::AID-CNCR2820171017>3.0.CO;2-0","article-title":"Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man","volume":"17","author":"Forni","year":"1964","journal-title":"Cancer"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-5347(17)56306-5","article-title":"The incidence of bladder cancer after cyclophosphamide therapy","volume":"122","author":"Fairchild","year":"1979","journal-title":"J Urol"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-5347(17)60025-9","article-title":"Cyclophosphamide and hemorrhagic cystitis","volume":"111","author":"Bennett","year":"1974","journal-title":"J Urol"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(83)92484-4","article-title":"Hemorrhagic Cystitis after low-dose cyclophosphamide","volume":"1","author":"Spiers","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.1999.5680","article-title":"Hemorrhagic pyelitis, ureteritis, and cystitis secondary to cyclophosphamide: case report and review of the literature","volume":"76","author":"Wong","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G","article-title":"Cyclophosphamide-induced hemorrhagic cystitis","volume":"61","author":"Stillwell","year":"1988","journal-title":"Cancer"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM198607243150405","article-title":"Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants","volume":"315","author":"Arthur","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/1097-0142(197001)25:1<7::AID-CNCR2820250103>3.0.CO;2-2","article-title":"Hemorrhagic cystitis and cytomegalic inclusions in the bladder associated with cyclophosphamide therapy","volume":"25","author":"Goldman","year":"1970","journal-title":"Cancer"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/archinte.1986.00360190186026","article-title":"Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation","volume":"146","author":"Ambinder","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FPC.0b013e328045c4fb","article-title":"Genetic polymorphisms of CYP2B6 affect the pharmakokinetics\/pharmacodynamics of cyclophosphamide in Japanese cancer patients","volume":"17","author":"Nakajima","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/FPC.0b013e328313aaa4","article-title":"Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa, and carboplatin","volume":"18","author":"Ekhart","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/jhg.2009.79","article-title":"Association study of genetic polymorphisms in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients","volume":"54","author":"Low","year":"2009","journal-title":"J Hum Genet"},{"key":"10.1111\/j.1524-4741.2011.01161.x-BIB16|cit16","unstructured":"Drug interactions: cytochrome P450 drug interaction table http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/table.asp"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-4741.2011.01161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1524-4741.2011.01161.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:26:36Z","timestamp":1643351196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-4741.2011.01161.x"}},"subtitle":["Low-Dose Cyclophosphamide and Hemorrhagic Cystitis"],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4741.2011.01161.x","relation":{},"ISSN":["1075-122X"],"issn-type":[{"value":"1075-122X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,5]]}}}